Capital Research Global Investors Cellebrite Di Ltd. Transaction History
Capital Research Global Investors
- $510 Billion
- Q3 2025
A detailed history of Capital Research Global Investors transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Capital Research Global Investors holds 2,425,736 shares of CLBT stock, worth $44.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,425,736
Previous 1,704,582
42.31%
Holding current value
$44.8 Million
Previous $27.3 Million
64.81%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CLBT
# of Institutions
215Shares Held
117MCall Options Held
445KPut Options Held
257K-
True Wind Capital Management, L.P.13.9MShares$256 Million94.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10MShares$185 Million0.11% of portfolio
-
Voss Capital, LLC Houston, TX6.78MShares$125 Million7.12% of portfolio
-
Invesco Ltd. Atlanta, GA5.56MShares$103 Million0.02% of portfolio
-
Pertento Partners LLP London, X04.65MShares$85.8 Million13.09% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.5B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...